Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 15:2024:2667033.
doi: 10.1155/2024/2667033. eCollection 2024.

COVID-19 Vaccines in the Pediatric Population: A Focus on Cardiac Patients

Affiliations
Review

COVID-19 Vaccines in the Pediatric Population: A Focus on Cardiac Patients

Ghena Lababidi et al. Can J Infect Dis Med Microbiol. .

Abstract

Due to the deleterious global impact of the COVID-19 pandemic, tremendous effort has been invested in the development of vaccines against the virus. Vaccine candidates are first tested in adult populations, a number of which have been approved for EUL by the WHO, and are in use across the USA and MENA region. The question remains whether these (or other) vaccines should be recommended to a neonatal, pediatric, and/or adolescent cohort. Incidence and severity of COVID-19 infection are low in pediatric, neonatal, and adolescent patients. Since both overall incidence and severity are lower in children than in adults, safety is an important consideration in vaccine approval for these age groups, in addition to efficacy and a decreased risk of transmission. The following review discusses vaccine immunology in children aged 0-18 years, with emphasis on the negative impact of the COVID-19 pandemic on the lives of children, considerations for pediatric vaccine approval, and available vaccines for pediatric cohorts along with a breakdown of the efficacy, advantages, and disadvantages for each. This review also contains current and future perspectives, as well as a section on the cardiovascular implications and related dynamics of pediatric COVID-19 vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Immunology of various COVID-19 vaccines [8] (this figure was developed using “Biorender” software).

Similar articles

References

    1. Roberton T., Carter E. D., Chou V. B., et al. Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study. Lancet Global Health . 2020;8(7):e901–e908. doi: 10.1016/s2214-109x(20)30229-1. - DOI - PMC - PubMed
    1. Falk G., Romero P. D., Nicchitta I. A., Nyhof E. C. Unemployment rates during the COVID-19 pandemic- congress. Unemployment Rates During the COVID-19 Pandemic . 2021 https://crsreports.congress.gov/product/pdf/R/R46554/9 .
    1. Nagakumar P., Chadwick C. L., Bush A., Gupta A. Collateral impact of COVID-19: why should children continue to suffer? European Journal of Pediatrics . 2021;180(6):1975–1979. doi: 10.1007/s00431-021-03963-x. - DOI - PMC - PubMed
    1. Cooper D. M., Afghani B., Byington C. L., et al. SARS-CoV-2 vaccine testing and trials in the pediatric population: biologic, ethical, research, and implementation challenges. Pediatric Research . 2021;90(5):966–970. doi: 10.1038/s41390-021-01402-z. - DOI - PMC - PubMed
    1. Contini D., Di Tommaso M. L., Muratori C., Piazzalunga D., Schiavon L. The COVID-19 pandemic and school closure: learning loss in mathematics in primary education. SSRN Electronic Journal . 2021 doi: 10.2139/ssrn.4114323. - DOI